当前位置: X-MOL 学术Mol. Ther. Nucl. Acids › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID.
Molecular Therapy - Nucleic Acids ( IF 6.5 ) Pub Date : 2018-07-05 , DOI: 10.1016/j.omtn.2018.06.011
Yun-Chao Xu 1 , Xu Liu 1 , Min Li 1 , Yan Li 2 , Chun-Yan Li 3 , Ying Lu 4 , Jaceline Sanches 1 , Lu Wang 1 , Yue Du 1 , Li-Min Mao 4 , Si-Bo Zuo 5 , Hui-Ting Liu 5 , Jie Shen 4 , Bo Wang 1 , Li Hou 1 , Lian-Hong Li 1 , Jian-Wu Tang 1 , Jing-Fang Ju 6 , Hong-Wei Guan 7 , Bo Song 1
Affiliation  

Doxorubicin is a widely used anthracycline-based anti-tumor agent for both solid and liquid tumors. Mounting evidence has demonstrated that microRNAs (miRNAs) are involved in chemoresistance and tumorigenesis. However, the roles of microRNA-501-5p (miR-501) in doxorubicin resistance and gastric cancer cell proliferation and invasion are still not fully understood. In this study, we identified that BLID (BH3-like motif-containing protein, cell death inducer) was directly regulated by miR-501 at the post-transcriptional level in multiple gastric cancer cell lines. Endogenous miR-501 was higher, whereas BLID was lower, in doxorubicin-resistant gastric cancer SGC7901/ADR cells compared with their parental SGC7901 cells. miR-501 suppressed gastric cancer cell apoptosis, induced resistance to doxorubicin, and enhanced cell proliferation, migration, and invasion. Subcutaneous injection of miR-501 lentivirus-infected SGC7901 cells resulted in rapid growth of xenograft tumors and resistance to doxorubicin treatment, unlike injection of negative miRNA lentivirus-infected SGC7901 cells. This is achieved at least partially by directly targeting BLID and subsequent inactivation of caspase-9 and caspase-3 and phosphorylation of Akt. Taken together, miR-501 induces doxorubicin resistance and enhances the tumorigenesis of gastric cancer cells by suppressing BLID. miR-501 might be a potential target for doxorubicin resistance and gastric cancer therapy.



中文翻译:

一种由 MicroRNA-501-5p 抑制的 BLID 介导的多柔比星抗性和肿瘤发生的新机制。

阿霉素是一种广泛用于实体和液体肿瘤的蒽环类抗肿瘤剂。越来越多的证据表明,微小 RNA (miRNA) 参与化学耐药性和肿瘤发生。然而,microRNA-501-5p (miR-501) 在多柔比星耐药和胃癌细胞增殖和侵袭中的作用仍未完全了解。在这项研究中,我们发现 BLID(含有 BH3 样基序的蛋白质,细胞死亡诱导剂)在多种胃癌细胞系的转录后水平上直接受 miR-501 调控。与其亲代 SGC7901 细胞相比,阿霉素耐药胃癌 SGC7901/ADR 细胞中的内源性 miR-501 更高,而 BLID 更低。miR-501 抑制胃癌细胞凋亡,诱导对多柔比星的耐药性,增强细胞增殖、迁移、和入侵。与注射阴性 miRNA 慢病毒感染的 SGC7901 细胞不同,皮下注射 miR-501 慢病毒感染的 SGC7901 细胞导致异种移植肿瘤的快速生长和对多柔比星治疗的抗性。这至少部分是通过直接靶向 BLID 并随后使 caspase-9 和 caspase-3 失活以及 Akt 磷酸化来实现的。总之,miR-501 诱导多柔比星耐药并通过抑制 BLID 增强胃癌细胞的肿瘤发生。miR-501 可能是阿霉素耐药和胃癌治疗的潜在靶点。这至少部分是通过直接靶向 BLID 并随后使 caspase-9 和 caspase-3 失活以及 Akt 磷酸化来实现的。总之,miR-501 诱导多柔比星耐药并通过抑制 BLID 增强胃癌细胞的肿瘤发生。miR-501 可能是阿霉素耐药和胃癌治疗的潜在靶点。这至少部分是通过直接靶向 BLID 并随后使 caspase-9 和 caspase-3 失活以及 Akt 磷酸化来实现的。总之,miR-501 诱导多柔比星耐药并通过抑制 BLID 增强胃癌细胞的肿瘤发生。miR-501 可能是阿霉素耐药和胃癌治疗的潜在靶点。

更新日期:2018-07-05
down
wechat
bug